Breaking News Instant updates and real-time market news.

NSP

Insperity

$113.88

-0.16 (-0.14%)

, LPNT

LifePoint

$64.94

0.03 (0.05%)

18:05
11/13/18
11/13
18:05
11/13/18
18:05

S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices

S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Insperity (NSP) will replace LifePoint Health (LPNT) in the S&P MidCap 400, and Eagle Bancorp (EGBN) will replace Insperity in the S&P SmallCap 600 effective at the market open on Monday, November 19. Apollo Global Management (APO) is acquiring LifePoint Health in a deal expected to close on or about that date pending final conditions.

NSP

Insperity

$113.88

-0.16 (-0.14%)

LPNT

LifePoint

$64.94

0.03 (0.05%)

EGBN

Eagle Bancorp

$49.19

0.48 (0.99%)

APO

Apollo Global

$29.00

-0.4 (-1.36%)

NSP Insperity
$113.88

-0.16 (-0.14%)

08/01/18
FANA
08/01/18
DOWNGRADE
Target $102
FANA
Equal-Weight
Insperity downgraded to Equal-Weight from Overweight at First Analysis
First Analysis analyst James Macdonald downgraded Insperity to Equal Weight from Overweight but raised his price target to $102 from $95 after its Q2 earnings beat and increased FY18 guidance. The analyst states that the stock is likely "fully valued", even though the current "late economic cycle" phase is typically "the best of times" for the company. Macdonald adds that the strong gross results in FY18 will create difficult comps for Insperity in FY19.
11/02/18
ROTH
11/02/18
NO CHANGE
Target $134
ROTH
Buy
Insperity's bsuiness fundamentals 'very strong' after Q3 beat, says Roth Capital
Roth Capital analyst Jeff Martin reiterated a Buy rating and $134 price target on Insperity shares after the company's Q3 results materially exceeded expectations, driven by accelerated worksite employee growth, coupled with healthy cost trends in the business and significant operating leverage. In a research note to investors, Martin says he believes nusiness fundamentals are very strong for Insperity, with increased value and flexibility of the service offering, ability to address the core small business and mid-market with higher retention rates and control of direct costs, and remains bullish on shares, although the valuation is well above historic average and peers. While not reflected in his 2019 model, Martin believe the market will likely demand 25-30% EBITDA growth to sustain the current valuation.
08/02/18
RHCO
08/02/18
NO CHANGE
Target $119
RHCO
Hold
Insperity price target raised to $119 from $85 at SunTrust
SunTrust analyst Tobey Sommer raised his price target on Insperity to $119 after its Q2 results showed "continued double-digit worksite employee growth". The analyst is also positive on the company's cost management and sales improvement and 99% client retention rate registered in the quarter. Sommer keeps his Hold rating on Insperity, citing its 19.6-times expected FY19 adjusted EBITDA valuation multiple, a slight premium to the industry average of 19-times.
08/01/18
ROTH
08/01/18
NO CHANGE
Target $123
ROTH
Buy
Insperity price target raised to $123 from $88 at Roth Capital
Roth Capital analyst Jeff Martin raised his price target for Insperity to $123 from $88 as he believes business fundamentals are very strong for the company, with increased value and flexibility of the service offering, ability to address the core small business and mid-market with higher retention rates and control of direct costs. The analyst remains bullish on the shares, although the valuation is well above historic average and peers. He reiterates a Buy rating on the shares.
LPNT LifePoint
$64.94

0.03 (0.05%)

11/07/18
MSCO
11/07/18
NO CHANGE
MSCO
Split Congress 'best outcome' for MCOs and hospitals, says Morgan Stanley
Morgan Stanley analyst Zack Sopcak contends that the Democratic party retaking the majority in the House of Representatives and Republicans retaining the Senate is the "best outcome" for Managed Care Organizations and hospitals, stating that he now sees another attempt at a repeal/replace of the Affordable Care Act as "off the table." The split Congress could also lower the volume on the "Medicare for All" debate given a lack of mandate from either the Democratic or Republican party, Sopcak tells investors. The election results remove a key overhang for Centene (CNC) and Molina (MOH), which he views as most exposed to the ACA marketplace, and to a lesser extent the hospitals, Sopcak added. With ACA repeal/replace off the table, and given the longer term potential upside from Medicaid expansion in Utah and Idaho as expansion ballot initiatives appear to be passing in both states, Sopcak said Molina is emerging as his top pick in the space heading into the final weeks of 2018. Publicly traded hospital companies include Community Health (CYH), HCA Healthcare (HCA), LifePoint (LPNT), Tenet (THC) and Universal Health (UHS).
07/24/18
BMOC
07/24/18
NO CHANGE
Target $62
BMOC
Market Perform
LifePoint price target raised to $62 from $51 at BMO Capital
BMO Capital analyst Matt Borsch raised his price target on LifePoint (LPNT) to $62 and kept his Market Perform rating after the proposed transaction for the company to be taken private by the Apollo Global (APO) affiliate RCCH HealthCare Partners at $65 per share. The analyst says his price target reflects the acquisition price blended with some uncertainty regarding the deal, even as he views the terms of the offer as attractive to LifePoint shareholders against the"backdrop of reimbursement and volume pressures that challenge acute care hospitals".
07/24/18
FBCO
07/24/18
NO CHANGE
Target $65
FBCO
Neutral
LifePoint price target raised to $65 from $58 at Credit Suisse
Credit Suisse analyst A.J. Rice raised his price target for LifePoint (LPNT) to $65 from $58 to reflect deal price after the company agreed to be acquired by Apollo Global (APO) affiliates for $65 per share. The analyst reiterates a Neutral rating on LifePoint shares.
07/24/18
BARD
07/24/18
DOWNGRADE
Target $65
BARD
Neutral
LifePoint downgraded to Neutral from Outperform at Baird
Baird analyst Matthew Gillmor downgraded LifePoint Health (LPNT) to Market Perform after the company agreed to be acquired by Apollo Global (APO) affiliates for $65 per share.
EGBN Eagle Bancorp
$49.19

0.48 (0.99%)

07/20/18
KBWI
07/20/18
NO CHANGE
Target $65
KBWI
Outperform
Eagle Bancorp selloff post earnings overdone, says Keefe Bruyette
Keefe Bruyette analyst Catherine Mealor views yesterday's post-earnings pullback in shares of Eagle Bancorp as overdone. The analyst lowered her price target for the stock to $65 from $70 and keeps an Outperform rating on the name. While the quarter was in-line, the 168% deposit beta is what drove the stock, Mealor tells investors in a research note. The analyst points out that even with the beta, net interest margin "held the line" at 4.15%, only down two basis points.
08/27/18
GABE
08/27/18
INITIATION
Target $74
GABE
Buy
Eagle Bancorp initiated with a Buy at Gabelli
Gabelli analyst Steve Comery initiated Eagle Bancorp with a Buy rating and $74 private market value estimate, stating that he views the recent pullback in the stock as an overreaction to deposit pricing and loan growth concerns. He sees the company's core competencies in commercial lending and noninterest deposits gathering as a sustainable competitive advantage, Comery tells investors.
01/19/18
SPHN
01/19/18
UPGRADE
Target $69
SPHN
Overweight
Eagle Bancorp upgraded to Overweight from Equal Weight at Stephens
Stephens analyst Austin Nicholas upgraded Eagle Bancorp to Overweight from Equal Weight, as he sees the bank's Q4 beat as evidence that its high-growth, efficient business model is intact. He thinks the stock should trade at a modest premium to Eagle's regional peers and in-line with its high profitability peers. Nicholas set a $69 price target on Eagle Bancorp shares.
12/04/17
SDLR
12/04/17
NO CHANGE
Target $65
SDLR
Buy
Eagle shares pricing in 'enough of the bad news,' says Sandler O'Neill
Sandler O'Neill analyst Casey Whitman believes "enough of the bad news has been baked in" with Eagle Bancorp shares down 25%. Following a short report, the fundamental question is the legality of the actions the bank and the CEO have taken, and the company's press releases seem to address those concerns, Whitman tells investors in a research note. He sees the worst case scenario as the regulators do find a problem and/or the CEO must step down. Whitman has a buy rating on Eagle with a $65 price target.
APO Apollo Global
$29.00

-0.4 (-1.36%)

08/14/18
MSCO
08/14/18
NO CHANGE
Target $42
MSCO
Overweight
Apollo Global's Q3 'setting up well,' says Morgan Stanley
Morgan Stanley analyst Michael Cyprys maintained an Overweight rating and $42 price target on Apollo Global, telling investors in a research note that Q3 is "setting up well" with key fund and balance sheet investments appreciating following a softer Q2 print. He sees Apollo's credit business scaling and new initiatives taking hold that could drive significant upside to fee-related earnings.
08/28/18
BUCK
08/28/18
NO CHANGE
BUCK
Buckingham sees RenaissanceRe, Axis Capital trading up on Aspen deal news
Buckingham analyst Amit Kumar called the multiple Apollo Global (APO) agreed to pay to acquire Aspen Insurance (AHL) "a tad underwhelming compared to other recent deals," which he attributes to Aspen's hand being forced by the fast approaching peak hurricane season and investor skepticism on its standalone future. Given the drawn out process, he sees a lower likelihood of a competing bidder emerging, Kumar tells investors, adding that he expects both RenaissanceRe (RNR) and Axis Capital (AXS) to trade up on the deal news.
10/01/18
GSCO
10/01/18
UPGRADE
Target $45
GSCO
Conviction Buy
Apollo Global upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Alexander Blostein added Apollo Global Management to his firm's Conviction List while keeping a Buy rating on the shares. Apollo at current valuation levels is now the only Alternative Manager to which the market still ascribes a negative value to future incentive earnings, Blostein tells investors in a research note. The analyst believes Apollo's investment performance is strengthening and its realization outlook is improving into 2019 and 2020. He has a $45 price target for the shares.

TODAY'S FREE FLY STORIES

TSEM

TowerJazz

$17.73

0.28 (1.60%)

06:32
04/24/19
04/24
06:32
04/24/19
06:32
Downgrade
TowerJazz rating change  »

TowerJazz downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 28

    May

MKTX

MarketAxess

$262.60

0.44 (0.17%)

06:32
04/24/19
04/24
06:32
04/24/19
06:32
Earnings
MarketAxess reports Q1 EPS $1.39, consensus $1.37 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 02

    May

SNAP

Snap

$11.99

0.46 (3.99%)

06:32
04/24/19
04/24
06:32
04/24/19
06:32
Upgrade
Snap rating change  »

Snap upgraded to In Line…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRK

Speedway Motorsports

$13.98

0.27 (1.97%)

06:32
04/24/19
04/24
06:32
04/24/19
06:32
Hot Stocks
Breaking Hot Stocks news story on Speedway Motorsports »

Sonic Financial proposes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

AMZN

Amazon.com

$1,924.08

35.98 (1.91%)

06:31
04/24/19
04/24
06:31
04/24/19
06:31
Periodicals
Amazon shifts thousands of workers amid delivery revamp, Yahoo Finance says »

Thousands of Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 22

    May

  • 03

    Jun

IART

Integra LifeSciences

$52.99

1.19 (2.30%)

06:28
04/24/19
04/24
06:28
04/24/19
06:28
Earnings
Integra LifeSciences sees Q2 adjusted EPS growth roughly 10% y/y, consensus 65c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 16

    May

NFLX

Netflix

$381.99

4.56 (1.21%)

, AMZN

Amazon.com

$1,924.08

35.98 (1.91%)

06:25
04/24/19
04/24
06:25
04/24/19
06:25
Periodicals
Academy votes not to change streaming Oscar eligibility, Reuters reports »

The Academy of Motion…

NFLX

Netflix

$381.99

4.56 (1.21%)

AMZN

Amazon.com

$1,924.08

35.98 (1.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 22

    May

  • 03

    Jun

CS

Credit Suisse

$13.26

-0.145 (-1.08%)

06:24
04/24/19
04/24
06:24
04/24/19
06:24
Hot Stocks
Credit Suisse says 'cautiously optimistic' about prospects for Q2 »

Credit Suisse said:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    Jun

CS

Credit Suisse

$13.26

-0.145 (-1.08%)

06:23
04/24/19
04/24
06:23
04/24/19
06:23
Earnings
Credit Suisse reports Q1 net income CHF749M »

Net income attributable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 03

    Jun

GNFT

Genfit

$25.47

0.46 (1.84%)

06:23
04/24/19
04/24
06:23
04/24/19
06:23
Initiation
Genfit initiated  »

Genfit initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

RDWR

Radware

$26.55

0.26 (0.99%)

06:22
04/24/19
04/24
06:22
04/24/19
06:22
Hot Stocks
Radware announces multi-million dollar deal with global courier services company »

Radware announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

HMI

Huami

$12.40

-0.21 (-1.67%)

06:22
04/24/19
04/24
06:22
04/24/19
06:22
Syndicate
Huami files to sell 7.9M ADSs »

The company proposes to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVE

Cenovus Energy

$10.44

0.01 (0.10%)

06:22
04/24/19
04/24
06:22
04/24/19
06:22
Hot Stocks
Cenovus Energy lowers FY19 total production view to 472-500 from 350-370 MBOE/d »

This marks a 7% reduction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

PG

Procter & Gamble

$103.19

-2.85 (-2.69%)

, MRK

Merck

$74.59

1.15 (1.57%)

06:21
04/24/19
04/24
06:21
04/24/19
06:21
Recommendations
Procter & Gamble, Merck analyst commentary at UBS »

Procter & Gamble…

PG

Procter & Gamble

$103.19

-2.85 (-2.69%)

MRK

Merck

$74.59

1.15 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 03

    May

  • 04

    May

  • 06

    May

  • 18

    May

  • 31

    May

  • 03

    Jun

  • 17

    Jun

  • 20

    Jun

  • 16

    Jul

  • 06

    Aug

  • 20

    Sep

SWK

Stanley Black & Decker

$147.37

1.89 (1.30%)

06:20
04/24/19
04/24
06:20
04/24/19
06:20
Earnings
Stanley Black & Decker raises FY19 adj. EPS view to $8.50-$8.70 from $8.45-$8.65 

Consensus $8.53.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

  • 16

    May

LULU

Lululemon

$176.83

3.82 (2.21%)

06:18
04/24/19
04/24
06:18
04/24/19
06:18
Periodicals
Lululemon CEO says company has no plans to reduce prices, WSJ reports »

Lululemon Athletica CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

KHC

Kraft Heinz

$33.09

0.2 (0.61%)

06:18
04/24/19
04/24
06:18
04/24/19
06:18
Downgrade
Kraft Heinz rating change  »

Kraft Heinz downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVE

Cenovus Energy

$10.44

0.01 (0.10%)

06:18
04/24/19
04/24
06:18
04/24/19
06:18
Earnings
Cenovus Energy reports Q1 operating EPS 6c, consensus (2c) »

Reports Q1 total liquids…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

K

Kellogg

$58.43

0.07 (0.12%)

06:18
04/24/19
04/24
06:18
04/24/19
06:18
Hot Stocks
Norway's wealth fund calls for annual elections to Kellogg's board »

Norges Bank Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 02

    May

SWK

Stanley Black & Decker

$147.37

1.89 (1.30%)

06:18
04/24/19
04/24
06:18
04/24/19
06:18
Earnings
Stanley Black & Decker reports Q1 adj. EPS $1.42, consensus $1.11 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

  • 16

    May

TRGP

Targa Resources

$40.92

-0.06 (-0.15%)

06:16
04/24/19
04/24
06:16
04/24/19
06:16
Initiation
Targa Resources initiated  »

Targa Resources resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ANTM

Anthem

$250.75

6.71 (2.75%)

06:16
04/24/19
04/24
06:16
04/24/19
06:16
Hot Stocks
Breaking Hot Stocks news story on Anthem »

Anthem backs FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 07

    May

  • 15

    May

  • 29

    May

ANTM

Anthem

$250.75

6.71 (2.75%)

06:15
04/24/19
04/24
06:15
04/24/19
06:15
Hot Stocks
Breaking Hot Stocks news story on Anthem »

Anthem backs FY19 medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 07

    May

  • 15

    May

  • 29

    May

TRWH

Twin River Worldwide

$32.57

-0.1 (-0.31%)

06:15
04/24/19
04/24
06:15
04/24/19
06:15
Initiation
Twin River Worldwide initiated  »

Twin River Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEL

TE Connectivity

$89.80

1.17 (1.32%)

06:15
04/24/19
04/24
06:15
04/24/19
06:15
Earnings
TE Connectivity raises FY19 adj. EPS view to $5.55-$5.65 from $5.35-$5.55 »

Consensus $5.44. Narrows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 07

    May

  • 29

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.